Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 4.  Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Published byMorgan Russell Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 4.  Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent."— Presentation transcript:

1 Table 4.  Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent serum samples from subjects with vaccine failure (F) and control subjects (C). From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12): doi: /509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

2 Table 3.  Immunoglobulin isotype and subclass deficiency in convalescent serum samples from subjects with vaccine failure, compared with those in unvaccinated subjects with meningococcal serogroup C disease. From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12): doi: /509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

3 Table 2.  Demographic details of the subjects with vaccine failure and unvaccinated control subjects.
From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12): doi: /509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

4 Table 1.  Classification by vaccination status of 462 subjects with confirmed meningococcal serogroup C (MenC) disease, in England and Wales between January 2000 and December 2003. From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12): doi: /509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

Download ppt "Table 4.  Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent."

Similar presentations

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.

Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.
Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.
Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Table 1. Baseline Characteristics of the 36,636 Study Subjects

Table 1. Baseline Characteristics of the 36,636 Study Subjects
Figure 1. Disposition of study participants, by group. Data are no

Figure 1. Disposition of study participants, by group. Data are no
Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.
Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.

Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.
Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.
Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.
From: Clinical and Laboratory Diagnosis of Dengue Virus Infection

From: Clinical and Laboratory Diagnosis of Dengue Virus Infection
From: Rotarix: A Rotavirus Vaccine for the World

From: Rotarix: A Rotavirus Vaccine for the World
Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37
Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.
Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Similar presentations

Ads by Google